CELZ — CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1187953 ·
Last close
$0.91
Market Cap
$5.92M
52W High
$4.72
52W Low
$0.79
ADV30
6,741,854
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | 0 | -1,459,153 | -1,405,077 | 6,440,577 | 5,723,176 | 307,649 |
| Dec 2025 | 3,000 | 2,006 | -1,945,782 | -1,887,674 | 7,809,525 | 7,208,126 | 284,880 |
| Sep 2025 | 0 | 0 | -1,273,034 | -1,235,934 | 5,853,003 | 5,375,511 | 261,353 |
| Jun 2025 | 0 | 0 | -1,263,520 | -1,233,303 | 7,105,228 | 6,544,120 | 277,644 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,856,445
Investing CF
$-50,500
Financing CF
$7,174,669
CapEx
—
Dividends Paid
—
Buybacks
$-10,000
EPS Diluted TTM
$-2.54
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-70,586,921
Inventory
$0
Receivables
$52,084
ST Investments
$0
EBIT TTM
$-6,142,814
Pretax Income TTM
$-5,995,008
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,000
EBITDA
$-5,819,884
Free Cash Flow
$-3,640,163
Enterprise Value
$-2,330,948
Total Cash
$5,848,176
Total Debt
$14,194
Shares Out
6,487,008
Trailing EPS
$-2.07
Book Value
$1.65
ROE
-81.2%
ROA
-50.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 6,000 | -6,142,814 | -5,995,008 | 7,809,525 | 284,880 | — | -5,856,445 |
| Dec 2024 | 11,000 | -5,743,861 | -5,493,481 | 6,669,143 | 327,644 | — | -5,301,292 |
| Dec 2023 | 9,000 | -5,620,132 | -5,286,574 | 10,715,190 | 371,394 | — | -8,027,885 |
| Dec 2022 | 88,600 | -10,244,372 | -10,144,044 | 19,186,326 | 3,321,652 | — | -7,796,966 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.86
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BCAB | BioAtla, Inc. | $6.34M | $3.82 | — |
| LIMN | Liminatus Pharma, Inc. | $7.07M | $0.11 | — |
| PMCB | PharmaCyte Biotech, Inc. | $7.48M | $0.70 | — |
| CPMV | Mosaic ImmunoEngineering Inc. | $4.63M | $0.64 | — |
| OPTEY | Opthea Ltd | $4.62M | $0.03 | — |
News headlines (Yahoo Finance, 1h cache)
Creative Medical Technology Holdings Issues Mid-Year Update
2026-07-01 13:00 · Yahoo
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
2026-06-30 18:07 · Yahoo
These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism?
2026-06-26 17:54 · Yahoo
Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
2026-06-22 13:15 · Yahoo
Creative Medical Technology opens nationwide burn-pit data registry
2026-06-16 19:49 · Yahoo
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
2026-06-16 13:00 · Yahoo
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
2026-04-28 13:01 · Yahoo
Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long
2026-04-09 10:56 · Yahoo
Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
2026-02-10 14:00 · Yahoo
Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
2026-01-13 14:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.